<?xml version="1.0" encoding="UTF-8"?>
<p>Nanomaterials impart many physical, chemical and biological advantages [
 <xref rid="B18-pharmaceutics-12-00171" ref-type="bibr">18</xref>,
 <xref rid="B197-pharmaceutics-12-00171" ref-type="bibr">197</xref>] such as: (1) small particle size in order to facilitate drug delivery through biological barriers, (2) large surface area to volume ratios to ensure large drug payloads, (3) tunable surface charge to facilitate cellular entry across the negatively charged cellular membrane, (4) biomimetic properties which result in intrinsic antiviral assets, (5) ability to anchor targeting moieties to increase specificity to desired cell types, tissue or other compartments, (6) improved solubility and pharmacokinetic and/or pharmacodynamics properties translated in longer time to allow greater accumulation, controlled and sustained release, (7) enhanced efficiency gained either by drug molecules entrapment to protect them from physiologically hostile media, or by using surface conjugation to target drugs to specific tissues, (8) reduced toxicity and (9) multifunctionality by combining several beneficial features in a stable construct, designed to simultaneously stimulate the replication of latent virus and deliver an antiviral to the activated cell [
 <xref rid="B198-pharmaceutics-12-00171" ref-type="bibr">198</xref>].
</p>
